Active ingredients
Pharmacological Group
Used in the treatment of
- S06 Intracranial injury
- R53 Malaise and fatigue
- R30.0 Dysuria
- I69 Sequelae of cerebrovascular disease
- I63 Cerebral infarction
- H47.0 Disorders of optic nerve, not elsewhere classified
- H40.1 Primary open-angle glaucoma
- H34 Retinal vascular occlusions
- T51 Toxic effect of alcohol
- G92 Toxic encephalopathy
- G43 Migraine
- F51.1 Nonorganic hypersomnia
- F45 Somatoform disorders
- F34.1 Dysthymia
- F32 Depressive episode
- F28 Other nonorganic psychotic disorders
- F13 Mental and behavioural disorders due to use of sedatives or hypnotics
- F11.2 Mental and behavioural disorders due to use of opioids, dependence syndrome
- F10.2 Mental and behavioural disorders due to use of alcohol, dependence syndrome
- F10.3 Mental and behavioural disorders due to use of alcohol, withdrawal state
- F07.1 Postencephalitic syndrome
- F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
- F03 Unspecified dementia
- F01 Vascular dementia
- E63 Other nutritional deficiencies
- F11 Mental and behavioural disorders due to use of opioids
- R41.3 Other amnesia